Simply Wall St.2d agoneutral
Halozyme Therapeutics (HALO) Following Record Results And Higher Guidance Is The Stock Still UndervaluedNotícias
Apenas manchetes de alto sinal - eventos macro, resultados, M&A, regulatório. Listicles e clickbait de analistas filtrados por padrão. Atualizado a cada hora.
102last 24h
3125last 7d
511● bullish (7d)
311● bearish (7d)
227publishers
GuruFocus.com2d agoneutral
Halozyme Stocks Slip 4.28% Despite 39% Revenue Growth and Modestly Higher GuidanceGuruFocus.com2d agoneutral
Halozyme Therapeutics Inc (HALO) (Q3 2026) Earnings Call Highlights: Record Revenue, Raised ...MT Newswires3d agoneutral
Halozyme Therapeutics Q3 Adjusted Earnings, Revenue Rise; 2026 Guidance LiftedPR Newswire3d agoneutral
HALOZYME REPORTS THIRD QUARTER 2026 RESULTS AND RAISES FULL YEAR 2026 FINANCIAL GUIDANCEGuruFocus.com93d agoneutral
Halozyme Therapeutics Inc (HALO) (Q2 2026) Earnings Call Highlights: Record Revenue and Royalty ...GuruFocus.com180d agoneutral
Halozyme Therapeutics Inc (HALO) Q1 2026 Earnings Call Highlights: Record Revenue Growth and ...MarketBeat187d agoneutral
Halozyme Therapeutics AGM: Shareholders Elect Directors as CEO Torley Raises 2026 Guidance